MedPath

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

Phase 2
Recruiting
Conditions
Temporomandibular Disorder
Bruxism
Myofascial Pain
CBD
Orofacial Pain
Interventions
Combination Product: 10% polymer gel with CBD application
Combination Product: 5% polymer gel with CBD application
Combination Product: Placebo intervention
Registration Number
NCT05562635
Lead Sponsor
Medical University of Silesia
Brief Summary

The aim of the project is to assess the effectiveness of reducing the masseter muscles tension and hyperactivity in patients with a painful form of TMD by using polymers containing CBD compared to placebo polymers.

Detailed Description

Since the healing properties of CBD have been known for a long time, the assumption of the proposed research is to reduce the tension of the masseter muscles, reduce the bruxism index and occlusal strength, as well as reduce pain, from which patients with TMD suffer.

CBD intraoral application therapy seems promising in that field. Patients attending The Department of TMD in Zabrze, Polska will be randomly divided into two groups: experimental and placebo. sEMG activity values will be compared during 14 and 30 days therapy with polymers. the efficacy of the cannabis cream used in the study. Positive results will confirm the efficacy of CBD relaxing properties used in the study, compared to placebo.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patient agreement to participate into the research study
  • Age ≥18 and ≤ 60
  • Good general health,
  • Temporomandibular disorder-positive RDC/TMD examination for group Ia and Ib
  • Presence of all teeth (with the exception of the third molars)
Exclusion Criteria
  • Cannabis cream/ placebo cream allergy
  • Hypersensitivity to substances to be used in the study
  • Wounds intra oral cavity
  • Addiction to cannabis
  • Patients being treated with analgesic drugs and/or drugs that affect muscle function

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
10 % polymers with CBD application10% polymer gel with CBD applicationBilateral application of 10% polymer gel with CBD intraorally, on the masseter muscle
5 % polymers with CBD application5% polymer gel with CBD applicationBilateral application of 5% polymer gel with CBD intraorally, on the masseter muscle
Placebo groupPlacebo interventionApplication of polymers without CBD on the masseter muscles, bilaterally
Primary Outcome Measures
NameTimeMethod
Change in masseter muscle electromyographic activity- sEMG examination30 days

Change in masseter muscle electromyographic activity-sEMG examination

Orofacial pain changes30 days

Changes of felt pain recorded by means of VAS scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of TMD

🇵🇱

Zabrze, Poland

© Copyright 2025. All Rights Reserved by MedPath